Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial.



Benedetto, Umberto ORCID: 0000-0002-7074-7949, Altman, Douglas G, Flather, Marcus, Gerry, Stephen ORCID: 0000-0003-4654-7311, Gray, Alastair ORCID: 0000-0003-0239-7278, Lees, Belinda, Taggart, David P and Arterial Revascularization Trial Investigators,
(2018) Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial. The Journal of thoracic and cardiovascular surgery, 155 (6). 2346 - 2355.e6.

[img] Text
Accepted_manuscript.pdf - Accepted Version

Download (713kB) | Preview

Abstract

BACKGROUND:The Arterial Revascularization Trial has been designed to answer the question whether the use of bilateral internal thoracic arteries can improve 10-year outcomes when compared with single internal thoracic arteries. In the Arterial Revascularization Trial, a significant proportion of patients initially allocated to bilateral internal thoracic arteries received other conduit strategies. We sought to investigate the incidence and clinical implication of bilateral internal thoracic artery graft conversion in the Arterial Revascularization Trial. METHODS:Among patients enrolled in the Arterial Revascularization Trial (n = 3102), we excluded those allocated to single internal thoracic arteries (n = 1554), those who did not undergo surgery (n = 16), and those who underwent operation but withdrew after randomization (n = 7). Propensity score matching was used to compare converted versus nonconverted bilateral internal thoracic artery groups. RESULTS:A total of 1525 patients were operated with the intention to receive bilateral internal thoracic artery grafting. Of those, 233 (15.3%) were converted to other conduit selection strategies. Incidence of conversion largely varied across 131 participating surgeons (from 0% to 100%). The most common reason for bilateral internal thoracic artery graft conversion was the evidence of at least 1 internal thoracic artery that was not suitable, which was reported in 77 cases. Patients with intraoperative bilateral internal thoracic artery graft conversion received a lower number of grafts (2.95 ± 0.84 vs 3.21 ± 0.74; P < .001). However, the hospital mortality rate was comparable to that of those who did not require bilateral internal thoracic artery graft conversion (0% vs 1.6%; P = .1), as well as the incidence of major complications. At 5 years, we found a nonsignificant excess of deaths (11.9% vs 8.4%; P = .1) and major adverse events (17.1% 13.2%; P = .1) mainly driven by an excess of revascularization in patients requiring conversion. CONCLUSIONS:The incidence of intraoperative bilateral internal thoracic artery graft conversion is not infrequent. Bilateral internal thoracic artery graft conversion is not associated with increased operative morbidity, but its effect on late outcomes remains uncertain.

Item Type: Article
Uncontrolled Keywords: Arterial Revascularization Trial Investigators, Mammary Arteries, Humans, Myocardial Infarction, Postoperative Complications, Coronary Artery Bypass, Internal Mammary-Coronary Artery Anastomosis, Incidence, Retrospective Studies, Aged, Middle Aged, Female, Male, Coronary Artery Disease, Propensity Score
Depositing User: Symplectic Admin
Date Deposited: 06 Jun 2019 07:39
Last Modified: 24 Jan 2020 09:11
DOI: 10.1016/j.jtcvs.2018.02.012
URI: http://livrepository.liverpool.ac.uk/id/eprint/3044690